ArriVent BioPharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
ArriVent BioPharma Inc
CIK #0001868279
EDGAR Form CIK 2011 - 2026
10-K [0001868279]
10-Q [0001868279]
3 [0001868279]
4 [0001868279]
8-K [0001868279]
D [0001868279]
SC 13D [0001868279]
SC 13G [0001868279]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Arrivent Biopharma Inc [2026-01-21]
Vanguard Group Inc Arrivent Biopharma Inc [2025-10-30]
HBM Healthcare Investments Cayman Ltd Arrivent Biopharma Inc [2025-10-15]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-08-13]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-05-15]
Novo Holdings A/S Arrivent Biopharma Inc [2025-02-14]
Suvretta Capital Management LLC Arrivent Biopharma Inc [2024-12-04]
HHLR Advisors Ltd Arrivent Biopharma Inc [2024-11-14]
FMR LLC Arrivent Biopharma Inc [2024-11-12]
Sofinnova Venture Partners Xi LP Arrivent Biopharma Inc [2024-11-12]
View All
Form 3/4/5 Subject 2011 - 2026
ArriVent BioPharma Inc
Hohneker John
Parsey Merdad
Nolet Chris
Peterson Kristine
Kastenmayer James Paul
Kung Winston
Yao Zhengbin
LaChapelle Robin
Lutzker Stuart
HHLR Advisors Ltd
Hillhouse Investment Management Ltd
Healy James
Gordon Carl L
OrbiMed Advisors IV Ltd
OrbiMed Capital GP VIII LLC
OrbiMed Advisors LLC
OrbiMed Asia GP IV LP
Jallal Bahija
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 130,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 150,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 140,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 550,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 130,000 $0.00
ArriVent BioPharma Inc AVBP
Common Stock
2025-12-10 Sell 555,555 $23.37 12,983,320
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 2,600 $2.28 5,928
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 2,050 $2.28 4,674
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 6,503 $2.28 14,827
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 2,600 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 6,503 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 2,050 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-04-28 Grant 28,346 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 380,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 120,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 120,000 $0.00
showing 20 of 64 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com